Chandra Cohen-Stavi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chandra Cohen-Stavi has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ran D. Balicer
Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel
4 shared publications - Morton Leibowitz
Clalit Research Institute, Chief Physician's Office, Clalit Health Services, 101 Arlozorov Street, Tel Aviv, Israel.
3 shared publications - Moshe Hoshen
Clalit Health Services, Petach Tikva, Israel
3 shared publications - Becca S. Feldman
Clalit Research Institute, Zamenhoff 42, Floor - 1, 6435331 Tel Aviv, Israel
2 shared publications - Craig S. Roberts
Health Economics and Outcomes Research, Pfizer Inc, 500 Arcola Road, Collegeville, PA, 19426, USA.
1 shared publication - Ilan Brufman
Clalit Research Institute, Chief Physician's Office, Clalit Health Services, Arlozorov 101, Tel Aviv, Israel
1 shared publication
Latest Publications
- 21 April 2017
- Published by Springer Nature in Current Cardiology Reports
- Vol. 19 (6) , 52
Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk
The aim of this study was to review and assess the evidence for low-density lipoprotein cholesterol (LDL-C) treatment goals as presented in current guidelines for primary and secondary prevention of cardiovascular disease.
- 21 April 2017
- Published by Springer Nature in Current Cardiology Reports
- Vol. 19 (6) , 52
Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk
The aim of this study was to review and assess the evidence for low-density lipoprotein cholesterol (LDL-C) treatment goals as presented in current guidelines for primary and secondary prevention of cardiovascular disease.
- Open Access
- 30 October 2014
- Published by Springer Nature in Population Health Metrics
- Vol. 12 (1) , 32
Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel
With increasing diabetes prevalence worldwide, an impending diabetes “pandemic” has been reported. However, definitions of incident cases and the population at risk remain varied and ambiguous. This study analyzed trends in mortality and screening that contribute to diabetes prevalence and incidence, distinguishing between new incident cases and newly detected cases. In an integrated provider-and-payer-system covering 53% of Israel’s population, a composite diabetes case-finding algorithm was built using diagnoses, lab tests, and antidiabetic medication purchases from the organization’s electronic medical record database. Data were extracted on adult members aged 26+ each year from January 1, 2004 through December 31, 2012. Rates of diabetes prevalence, incidence, screening, and mortality were reported, with incidence rates evaluated among the total, “previously-screened,” and “previously-unscreened” at-risk populations. There were 343,554 diabetes cases in 2012 (14.4%) out of 2,379,712 members aged 26+. A consistent but decelerating upward trend in diabetes prevalence was observed from 2004-2012. Annual mortality rates among diabetics decreased from 13.8/1000 to 10.7/1000 (p = 0.0002). Total population incidence rates declined from 13.3/1000 in 2006 to 10.8/1000 in 2012 (p < 0.0001), with similar incidence trends (13.2/1000 to 10.2/1000; p = 0.0007) among previously-screened at-risk members, and a rise in testing rates from 53.0% to 66.7% (p = 0.0004). The previously-unscreened group decreased 28.6%, and the incidence rates within this group remained stable. The increase in diabetes prevalence is decelerating despite declining mortality and increasing testing rates. A decline in previously-screened incident cases and a shrinking pool of previously-unscreened members suggests that diabetes trends in Israel are moving toward equilibrium, rather than a growing epidemic.
- 30 October 2014
- Published by Springer Nature in Population Health Metrics
- Vol. 12 (1) , 32
Open AccessTowards a subsiding diabetes epidemic: trends from a large population-based study in Israel
With increasing diabetes prevalence worldwide, an impending diabetes “pandemic” has been reported. However, definitions of incident cases and the population at risk remain varied and ambiguous. This study analyzed trends in mortality and screening that contribute to diabetes prevalence and incidence, distinguishing between new incident cases and newly detected cases. In an integrated provider-and-payer-system covering 53% of Israel’s population, a composite diabetes case-finding algorithm was built using diagnoses, lab tests, and antidiabetic medication purchases from the organization’s electronic medical record database. Data were extracted on adult members aged 26+ each year from January 1, 2004 through December 31, 2012. Rates of diabetes prevalence, incidence, screening, and mortality were reported, with incidence rates evaluated among the total, “previously-screened,” and “previously-unscreened” at-risk populations. There were 343,554 diabetes cases in 2012 (14.4%) out of 2,379,712 members aged 26+. A consistent but decelerating upward trend in diabetes prevalence was observed from 2004-2012. Annual mortality rates among diabetics decreased from 13.8/1000 to 10.7/1000 (p = 0.0002). Total population incidence rates declined from 13.3/1000 in 2006 to 10.8/1000 in 2012 (p < 0.0001), with similar incidence trends (13.2/1000 to 10.2/1000; p = 0.0007) among previously-screened at-risk members, and a rise in testing rates from 53.0% to 66.7% (p = 0.0004). The previously-unscreened group decreased 28.6%, and the incidence rates within this group remained stable. The increase in diabetes prevalence is decelerating despite declining mortality and increasing testing rates. A decline in previously-screened incident cases and a shrinking pool of previously-unscreened members suggests that diabetes trends in Israel are moving toward equilibrium, rather than a growing epidemic.
- 1 July 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 174 (3) , 773-774
Reduction in myocardial infarction incidence: Focus on socioeconomic disparities
- 1 July 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 174 (3) , 773-774
Reduction in myocardial infarction incidence: Focus on socioeconomic disparities